These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16282861)

  • 1. Comments on article by Albers et al: "Low-dose fluvoxamine as an adjunct to reduce olanzapine therapeutic dose requirements: a prospective dose-adjusted drug interaction strategy".
    Chiu CC; Lu ML
    J Clin Psychopharmacol; 2005 Dec; 25(6):626-7; author reply 627-8. PubMed ID: 16282861
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose fluvoxamine as an adjunct to reduce olanzapine therapeutic dose requirements: a prospective dose-adjusted drug interaction strategy.
    Albers LJ; Ozdemir V; Marder SR; Raggi MA; Aravagiri M; Endrenyi L; Reist C
    J Clin Psychopharmacol; 2005 Apr; 25(2):170-4. PubMed ID: 15738749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of olanzapine with fluvoxamine.
    de Jong J; Hoogenboom B; van Troostwijk LD; de Haan L
    Psychopharmacology (Berl); 2001 May; 155(2):219-20. PubMed ID: 11401013
    [No Abstract]   [Full Text] [Related]  

  • 4. Navigating the co-prescription of clozapine and fluvoxamine.
    Shymko G; Clark V; Shymko L; Waters F
    Schizophr Res; 2018 Dec; 202():391-393. PubMed ID: 30269927
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia.
    Chiu CC; Lane HY; Huang MC; Liu HC; Jann MW; Hon YY; Chang WH; Lu ML
    J Clin Pharmacol; 2004 Dec; 44(12):1385-90. PubMed ID: 15545309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvoxamine augmentation in clozapine-resistant schizophrenia: an open pilot study.
    Silver H; Kushnir M; Kaplan A
    Biol Psychiatry; 1996 Oct; 40(7):671-4. PubMed ID: 8886304
    [No Abstract]   [Full Text] [Related]  

  • 7. Dosing strategies of clozapine-fluvoxamine cotreatment.
    Lu ML; Lane HY; Jann MW; Chang WH
    J Clin Psychopharmacol; 2002 Dec; 22(6):626-8. PubMed ID: 12454566
    [No Abstract]   [Full Text] [Related]  

  • 8. Olanzapine augmentation of fluoxetine in trichotillomania: two cases.
    Srivastava RK; Sharma S; Tiwari N; Saluja B
    Aust N Z J Psychiatry; 2005; 39(1-2):112-3. PubMed ID: 15660718
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypersalivation induced by olanzapine with fluvoxamine.
    Hori T; Makabe K; Nemoto K; Asada T
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):758-60. PubMed ID: 16574294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effective treatment of depressive disorder with psychotic symptoms by olanzapine combination therapy].
    Schmitt A; Braus DF
    Dtsch Med Wochenschr; 2000 Dec; 125(50):1526-9. PubMed ID: 11190762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of valproate on olanzapine plasma concentrations in patients with bipolar or schizoaffective disorder.
    Spina E; D'Arrigo C; Santoro V; Muscatello MR; Pandolfo G; Zoccali R; Diaz FJ; de Leon J
    Ther Drug Monit; 2009 Dec; 31(6):758-63. PubMed ID: 19865002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of olanzapine augmentation of paroxetine therapy in patients with severe body dysmorphic disorder.
    Nakaaki S; Murata Y; Furukawa TA
    Psychiatry Clin Neurosci; 2008 Jun; 62(3):370. PubMed ID: 18588607
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluvoxamine-associated oscillopsia and a role for personalized medication dosing.
    Singman EL; Hocum B; Yohannan J; Pearson V
    Drug Metab Pers Ther; 2015 Dec; 30(4):271-5. PubMed ID: 26351962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvoxamine and perphenazine for psychosis in Alzheimer's disease: pharmacokinetic considerations.
    Baumann P; Eap CB; Zullino DF
    J Nerv Ment Dis; 2001 Nov; 189(11):798-9. PubMed ID: 11758666
    [No Abstract]   [Full Text] [Related]  

  • 15. Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial.
    Bogetto F; Bellino S; Vaschetto P; Ziero S
    Psychiatry Res; 2000 Oct; 96(2):91-8. PubMed ID: 11063782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single dose of fluvoxamine associated with an acute psychotic reaction.
    Sim FH; Massabki RA
    Can J Psychiatry; 2000 Oct; 45(8):762. PubMed ID: 11086561
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and pharmacokinetics of fluvoxamine maleate in patients with mild depression undergoing hemodialysis.
    Kamo T; Horikawa N; Tsuruta Y; Miyasita M; Hatakeyama H; Maebashi Y
    Psychiatry Clin Neurosci; 2004 Apr; 58(2):133-7. PubMed ID: 15009816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The differential effects of steady-state fluvoxamine on the pharmacokinetics of olanzapine and clozapine in healthy volunteers.
    Wang CY; Zhang ZJ; Li WB; Zhai YM; Cai ZJ; Weng YZ; Zhu RH; Zhao JP; Zhou HH
    J Clin Pharmacol; 2004 Jul; 44(7):785-92. PubMed ID: 15199083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration-response relationship for fluvoxamine using remission as an endpoint: a receiver operating characteristics curve analysis in major depression.
    Suzuki Y; Fukui N; Sawamura K; Sugai T; Watanabe J; Ono S; Inoue Y; Ozdemir V; Someya T
    J Clin Psychopharmacol; 2008 Jun; 28(3):325-8. PubMed ID: 18480690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypharmacy of 2 atypical antipsychotics.
    Rhoads E
    J Clin Psychiatry; 2000 Sep; 61(9):678-80. PubMed ID: 11030491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.